DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

1.77 0.04 (2.31%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PLX $1.77 2.31%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.72
Previous Close $1.73
Daily Range $1.70 - $1.79
52-Week Range $1.53 - $5.00
Market Cap $165.7M
P/E Ratio -5.41
Dividend (Yield) $0.00 (0.0%)
Volume 83,449
Average Daily Volume 132,082
Current FY EPS -$0.06

Sector

Healthcare

Industry

Drug Makers

Protalix BioTherapeutics, Inc. (PLX) Description

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system. Website: http://www.protalix.com/

News & Commentary Rss Feed

3 High-Risk, High-Reward Biotech Stocks for Long Term Investors

Everyone wants to get rich, but investing in the wrong developmental companies can have disastrous consequences. Here are three companies with game-changing potential that have yet to hit their stride -- and may payoff in the long run.

Protalix BioTherapeutics (PLX): An Off-the-Radar Potential Winner - Tale of the Tape

Protalix BioTherapeutics (PLX): An Off-the-Radar Potential Winner - Tale of the Tape

Health Care Sector Update for 02/12/2015: PLX, THLD, ACOR

Protalix Finishes Patient Enrollment for Fabry Disease Study - Analyst Blog

Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

Pharmaceuticals, Therapeutics And A Retailer On The Move Thursday Morning

Protalix BioTherapeutics, Inc. (PLX) Jumps: Stock Rises 16% - Tale of the Tape

Health Care Sector Update for 01/05/2015: PLX,CNAT,BCLI

Monday Sector Leaders: Biotechnology, Drugs

Avago Technologies' Memory, FBAR, and Connectivity Business Will Take It Higher

5 Stocks Ready to Break Out and Soar Higher

See More PLX News...

PLX's Top Competitors

PLX $1.77 (2.31%)
Current stock: PLX
AMGN $162.59 (1.27%)
Current stock: AMGN
GILD $101.00 (-0.07%)
Current stock: GILD
BIIB $429.87 (0.22%)
Current stock: BIIB